Credit Suisse Ag Outset Medical, Inc. Transaction History

Credit Suisse Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$10.52 - $20.68 $24,900 - $48,949	-2,367 Reduced 5.2%	43,127 $469,000
Q2 2023 Aug 11, 2023	SELL	$17.18 - $23.76 $91,449 - $126,474	-5,323 Reduced 10.47%	45,494 $994,000
Q1 2023 May 10, 2023	BUY	$18.25 - $30.26 $32,466 - $53,832	1,779 Added 3.63%	50,817 $935,000
Q4 2022 Feb 13, 2023	BUY	$12.36 - $26.41 $168,553 - $360,153	13,637 Added 38.52%	49,038 $1.27 Million
Q3 2022 Nov 10, 2022	SELL	$14.67 - $21.7 $14,215 - $21,027	-969 Reduced 2.66%	35,401 $564,000
Q2 2022 Aug 12, 2022	BUY	$13.46 - $48.16 $1,655 - $5,923	123 Added 0.34%	36,370 $540,000
Q1 2022 May 16, 2022	BUY	$34.22 - $47.24 $213,156 - $294,257	6,229 Added 20.75%	36,247 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$43.29 - $58.77 $231,298 - $314,008	5,343 Added 21.65%	30,018 $1.38 Million
Q3 2021 Nov 12, 2021	BUY	$36.86 - $54.98 $54,626 - $81,480	1,482 Added 6.39%	24,675 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$41.49 - $59.92 $694,252 - $1 Million	16,733 Added 259.02%	23,193 $1.16 Million
Q1 2021 May 14, 2021	BUY	$46.94 - $58.66 $303,232 - $378,943	6,460 New	6,460 $351,000

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.